- Q1 2024 Allogene Therapeutics Inc Earnings Call TranscriptMay 13, 2024$2.9 (+5.07%)Earnings
- Q4 2023 Allogene Therapeutics Inc Earnings Call TranscriptMar 14, 2024$4.5 (-7.89%)Earnings
- Allogene Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- Allogene Therapeutics Inc Platform Vision Call TranscriptJan 04, 2024
- Q3 2023 Allogene Therapeutics Inc Earnings Call TranscriptNov 02, 2023$2.97 (+4.95%)Earnings
- Q2 2023 Allogene Therapeutics Inc Earnings Call TranscriptAug 02, 2023$4.69 (-2.09%)Earnings
- Allogene Therapeutics Inc at Goldman Sachs Healthcare Conference TranscriptJun 14, 2023
- Allogene Therapeutics Inc at Jefferies Healthcare Conference TranscriptJun 09, 2023
- Allogene Therapeutics Inc at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 Allogene Therapeutics Inc Earnings Call TranscriptMay 03, 2023$5.72 (+6.92%)Earnings
- Q4 2022 Allogene Therapeutics Inc Earnings Call TranscriptFeb 28, 2023$6.35 (+0.32%)Earnings
- Allogene Therapeutics Inc at B Riley Securities Oncology Conference (Virtual) TranscriptJan 18, 2023
- Allogene Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 10, 2023
- Allogene Therapeutics Inc R&D Showcase TranscriptNov 29, 2022
- Allogene Therapeutics Inc at Cowen IO Next Summit (Virtual) TranscriptNov 11, 2022
- Q3 2022 Allogene Therapeutics Inc Earnings Call TranscriptNov 02, 2022$10.17 (-3.78%)Earnings
- Q2 2022 Allogene Therapeutics Inc Earnings Call TranscriptAug 09, 2022$15.03 (-5.83%)Earnings
- Allogene Therapeutics Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 13, 2022
- Allogene Therapeutics Inc at Bank of America Healthcare Conference TranscriptMay 10, 2022
- Q1 2022 Allogene Therapeutics Inc Earnings Call TranscriptMay 04, 2022$9.43 (+4.31%)Earnings
- Q4 2021 Allogene Therapeutics Inc Earnings Call TranscriptFeb 23, 2022$9.17 (-5.66%)Earnings
- Allogene Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Allogene Therapeutics Inc Business Update Call TranscriptJan 10, 2022
- Allogene Therapeutics Inc to Review ALPHA, ALPHA2 and UNIVERSAL Phase 1 Data Presented at the American Society of Hematology Annual Meeting TranscriptDec 13, 2021
- Q3 2021 Allogene Therapeutics Inc Earnings Call TranscriptNov 04, 2021$19.43 (-3.62%)Earnings
- Allogene Therapeutics Inc Business Update- Conference Call TranscriptOct 07, 2021
- Q2 2021 Allogene Therapeutics Inc Earnings Call TranscriptAug 04, 2021$22.13 (+0.91%)Earnings
- Allogene Therapeutics Inc at Bank of America NAPA Healthcare Conference TranscriptJun 15, 2021
- Allogene Therapeutics Inc Annual Shareholders Meeting TranscriptJun 10, 2021
- Allogene Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- Allogene Therapeutics Inc at Jefferies Healthcare Conference (Virtual) TranscriptJun 01, 2021
- Allogene Therapeutics Inc to Host Virtual CD19 Forum TranscriptMay 19, 2021
- Q1 2021 Allogene Therapeutics Inc Earnings Call TranscriptMay 05, 2021$28.71 (-2.31%)Earnings
- Q4 2020 Allogene Therapeutics Inc Earnings Call TranscriptFeb 25, 2021$32.79 (-4.79%)Earnings
- Allogene Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Allogene Therapeutics Inc to Review The Potential Innovation of Allogeneic CAR T Therapy in Multiple Myeloma TranscriptDec 05, 2020
- Q3 2020 Allogene Therapeutics Inc Earnings Call TranscriptNov 04, 2020$31.06 (-8.08%)Earnings
- Allogene Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 14, 2020
- Q2 2020 Allogene Therapeutics Inc Earnings Call TranscriptAug 05, 2020$38.45 (+3.69%)Earnings
- Allogene Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2020
- Allogene Therapeutics Inc Annual Shareholders Meeting TranscriptJun 05, 2020
- Q1 2020 Allogene Therapeutics Inc Earnings Call TranscriptMay 06, 2020$30.07 (-2.56%)Earnings
- Q4 2019 Allogene Therapeutics Inc Earnings Call TranscriptFeb 27, 2020$25.92 (+1.85%)Earnings
- Allogene Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Q3 2019 Allogene Therapeutics Inc Earnings Call TranscriptNov 05, 2019$27.66 (-4.36%)Earnings
- Allogene Therapeutics Inc at Morgan Stanley Healthcare Conference TranscriptSep 09, 2019
- Q2 2019 Allogene Therapeutics Inc Earnings Call TranscriptAug 07, 2019$29.59 (-0.54%)Earnings
- Q1 2019 Allogene Therapeutics Inc Earnings Call TranscriptMay 07, 2019$29.79 (-4.18%)Earnings
- Q4 2018 Allogene Therapeutics Inc Earnings Call TranscriptMar 08, 2019$28.38 (-4.28%)Earnings
Allogene Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Good afternoon, everyone. Thank you for joining us for another session at the 41st Annual JPMorgan Healthcare Conference. My name is Brian Cheng. I'm one of the senior biotech analysts here at the firm. Presenting next is Allogene. With us today, we have President and CEO of Allogene, David Chang.
I'll turn over the stage to David, and then the presentation will be followed by a Q&A session.
Thank you, Brian, for hosting us, and thank you for those who are in the audience. So I will be making some forward-looking statements, which will be subject to the disclosures we have in the SEC filing.
So Allogene is really here to democratize the cell therapy and our mission is for the patients. And we have 6 foundational platforms from AlloCAR T, TurboCAR T, Cloak & Dagger, manufacturing as well as iPSC programs to fuel the innovation. Also, we distinguish ourselves by having
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)